Total patients | Benign N (%) | Malignant N (%) | Non-neoplastic | RR (95% CI) | P-value | |
---|---|---|---|---|---|---|
Early Age (11–13) | 12 | 4 (33.3) | 1 (8.3) | 7 {58.3%} | 0.25 (0.03, 1.92) | 0.1829 |
Middle Age (14–16) | 59 | 15 (25.4) | 4 (6.8) | 40 {67.8%} | 0.27 (0.09, 0.76) | 0.0129 |
Late Age (17–21) | 93 | 30 (32.3) | 10 (10.7) | 53 {57%} | 0.33 (0.17, 0.64) | 0.0010 |